Shares Outstanding: 25.05m
Cash: 20.9m
Current liabilities: 20.05m
Current ratio: 1.9
NWC (total current assets - total current liabilities): 18.01m
Monthly Burn rate (net cash used in operating activities / months): 5.51m
Estimated current cash: 9.8m
Accumulated deficit: 117.8m
Book value per share (Stock holder equity / Shares outstanding): -1.377
Baby Shelf Exemption price per share: 2.99
-Gained momentum in November
-Broke resistances since mid 2019
-Had an inside day
REFILE-FDA approves Aquestive's ALS treatment
Only diluted 100k shares since 2018
Making ~50m per year in revenue
September 2019 ATM S-3 for $150m
$17m ATM propectus (unused)
Prospectus for 2m shares of common stock by selling stockholder (unused)
First Test of 7.25 level
Had my fantasy orders set but only 1 order got hit before it popped up, took profits quickly: One Good Trade.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2019-11-25 09:48:54 | AQST | buy | $7.280 | long |
2019-11-25 09:49:57 | AQST | sell | $7.400 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!